RHB Retail Research
Trading Stocks (mid-day) - Duopharma Biotech
At the time of writing, Duopharma Biotech was holding below the MYR1.60 resistance. If a decisive breakout occurs, a bullish bias may be present above this point with a target price of MYR1.70, followed by MYR1.78. The stock may consolidate further if it cannot decisively breach above the MYR1.60 mark in the coming sessions. Support may be found at MYR1.51, where traders can exit upon a breach to limit the downside risk.
Source: RHB Securities Research - 12 May 2020
Related Stocks
| Chart | Stock Name | Last | Change | Volume |
|---|
More articles on RHB Retail Research
Duopharma Biotech - Lacking Near-Term Re-Rating Catalysts; D/G NEUTRAL
Created by rhboskres | Aug 26, 2024
Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment
Featured Posts
Latest Videos
Apps
Top Articles
1
2
4
save malaysia!
Visa-free travel to China extended for Malaysians to 30 days
5
6
7
Good Articles to Share
Iran to hold nuclear talks with three European powers in Geneva on Friday, Kyodo reports
8
#
Stock
Score
Daily Stocks
Stock Name
Last
Change
Volume
Stock Name
Last
Change
Volume
Stock Name
Last
Change
Volume
Featured Advertisers / Partners
Ride The Bull Short The Bear
CS Tan
4.9 / 5.0
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
